semaglutide oral efficacy found to lower risk of heart failure events in people with type 2 diabetes ECO 2026 - OASIS 4:

Interestingly, glucagon-like peptide-1 receptor agonists (GLP-1RAs), used in the treatment of T2DM and obesity, are known to show pro-cognitive and neuroprotective properties, and exert modulatory effects on immune, endocrine and metabolic processes in the central nervous system

TCHOL, total cholesterol

By regulating insulin, cortisol, thyroid hormones, and reproductive hormones , Semaglutide injections offer comprehensive metabolic and hormonal health benefits

Disease states that affect intra-portal insulin levels by increasing insulin resistance causing compensatory intra-portal hyperinsulinemia or by decreasing pancreatic -cell insulin secretion causing intra-portal hypoinsulinemia results in changes to hepatic IGF-I synthesis and secretion, and consequently changes in GH levels via the negative feedback loop